Can Semaglutide Cause Muscle Loss?

What the STEP 1 trial found about body composition

The most rigorous data comes from the STEP 1 trial, published in the New England Journal of Medicine, which followed 1,961 adults with obesity over 68 weeks. Participants on semaglutide 2.4mg lost an average of around 15% of their body weight. Sub-studies using DEXA scans (the gold standard for separating fat from lean tissue) found that the majority of this was fat mass, but lean mass also fell.

That finding sounds alarming until you look at the proportion. Research consistently shows that when people lose weight by any method, roughly 20–30% of the mass lost tends to be lean tissue (muscle, bone, connective tissue) rather than pure fat. The semaglutide data sits within that expected range. If you want to understand whether Wegovy actually causes muscle loss or simply reflects the expected pattern of any calorie deficit, the distinction matters enormously. What it tells us is that semaglutide does not appear to selectively attack muscle; the lean mass reduction tracks broadly with the overall calorie deficit the drug helps create by suppressing appetite.

There is one important nuance. Very rapid weight loss tends to carry a higher proportion of lean tissue loss than slower, more moderate loss. Because semaglutide can meaningfully suppress appetite, people who do not pay attention to protein and activity may lose lean mass faster than they would with a gentler calorie cut. That is the clinical concern, not a unique pharmacological effect on muscle fibres.

Why the rate of weight loss changes the muscle picture

When the body is in a significant energy deficit, it draws on stored fat first, but it also draws on amino acids from muscle, particularly if dietary protein is low. The NHS medicines page for semaglutide notes that treatment should be used alongside a reduced-calorie diet and increased physical activity, not as a standalone intervention. That pairing is not incidental. It directly addresses the muscle-loss question.

Resistance exercise (anything from bodyweight circuits to gym weights) sends a strong signal to the body to preserve muscle even during a deficit. Protein intake matters equally: current UK dietary guidance and the clinical literature both point to adequate protein as the primary nutritional buffer against lean mass reduction during weight loss. Spreading protein across meals (rather than loading it at one sitting) improves how efficiently the body uses it.

If you are mid-treatment and wondering how your dose level might relate to appetite suppression and food intake, our page on how semaglutide works covers the mechanism in more detail. For people specifically weighing Wegovy's muscle effects, our guide to how Wegovy relates to muscle loss goes deeper into the injection-specific evidence.

What you can actually do about it, practically

The good news is that muscle loss during semaglutide treatment is largely modifiable. Three things make the biggest practical difference.

First, keep protein intake up. Many people find their appetite drops so much on semaglutide that overall food volume falls sharply, which is the point, but it can mean protein drops with everything else. Prioritising protein-dense foods (eggs, Greek yoghurt, chicken, legumes) within a smaller daily intake helps preserve lean mass.

Second, do not abandon resistance exercise. Even two sessions a week of moderate resistance work appears to reduce the proportion of weight loss that comes from lean tissue. Walking is valuable for general health, but it does not protect muscle the way load-bearing exercise does.

Third, do not rush titration for the sake of it. The dosing schedule exists partly to manage tolerability, and staying at a manageable dose level often means steadier, more sustainable weight loss with less acute calorie-crash. A prescriber decides titration timing based on your individual response.

One practical note: patients sometimes pause treatment over a bank holiday or before a long trip, then restart and find their appetite returns temporarily before resettling. Planning nutrition and exercise around those windows helps avoid the unintentional lean-mass dips that can come with stop-start patterns.

When to talk to a prescriber about your muscle concerns

Muscle-related symptoms during semaglutide treatment deserve proper attention. Some patients also want to know whether Wegovy can cause muscle pain as a direct side effect, which is a different question from the soreness that comes with exercise, and one worth understanding before assuming discomfort is routine. If you notice significant weakness, unexpected fatigue, or you are unsure whether the discomfort you are feeling is a side effect worth acting on, our page on whether Wegovy can cause muscle aches covers the distinction between exercise soreness and symptoms that warrant clinical review.

There is also a separate, genuinely interesting question: can semaglutide users actually build muscle or maintain strength during treatment? The evidence here is early but not discouraging, some studies suggest body composition outcomes improve considerably when resistance training is added. The semaglutide and muscle gain page explores what that research currently shows.

If you are thinking about whether treatment is right for your situation, including your activity level and current body composition, a clinical consultation is the right starting point. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, on the same day it is submitted. There are no algorithms triaging your health history. Check your eligibility and start your free consultation to speak with our prescribers about what is appropriate for you.